# Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy

> **NCT05695573** · — · COMPLETED · sponsor: **Tanta University** · enrollment: 100 (actual)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DIAGNOSTIC_TEST:** ACR, fasting, postprandial blood glucose ,HbA1c, creatinine, cystatin-C, BUN, Na, K , lipid profile

## Key facts

- **NCT ID:** NCT05695573
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-05
- **Primary completion:** 2022-04-28
- **Final completion:** 2022-06-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05695573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05695573, "Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05695573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*